Company Filing History:
Years Active: 1996
Title: The Innovations of Jeffrey S. Fleitman
Introduction
Jeffrey S. Fleitman is a notable inventor based in Sunnyvale, CA, who has made significant contributions to the field of pharmaceuticals. With a total of 2 patents, his work focuses on the development of innovative pharmaceutical compositions and formulations.
Latest Patents
Fleitman's latest patents include a process for preparing pharmaceutical compositions containing crystalline forms of mycophenolate mofetil. One patent details the crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate, and acetate, particularly the hydrochloride salt. This patent also covers pharmaceutical compositions, intravenous formulations, and a kit thereof, along with associated methods of treatment. Another patent similarly addresses crystalline anhydrous mycophenolate mofetil and its intravenous formulation, emphasizing the same complexing process and its applications in treatment.
Career Highlights
Jeffrey S. Fleitman is associated with Syntex (U.S.A.) Inc., where he has been instrumental in advancing pharmaceutical innovations. His expertise in the field has led to the development of critical formulations that enhance the efficacy of treatments.
Collaborations
Fleitman has collaborated with notable colleagues, including Roger C. Fu and De-Mei Leung, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jeffrey S. Fleitman's contributions to pharmaceutical inventions highlight his role as a key innovator in the industry. His patents reflect a commitment to improving treatment options through advanced formulations.